Abstract
In the process of tumour progression genetic instability is the basis for the evolution of tumour cell clones with various genotypic and phenotypic characteristics causing heterogeneity. Renal cell carcinoma has a long prediagnostic growth period, which increases the probability of clonal evolution. We have studied 200 consecutive renal cell carcinomas, addressing the interrelationship between intratumour heterogeneity and clinicopathological factors. DNA ploidy patterns were analysed in multiple samples from each tumour using flow cytometry and compared with clinical stage, tumour invasion, metastatic rate and survival. Eighty-five of 192 evaluable tumours (44%) were homogeneous concerning DNA ploidy (62% diploid, 38% aneuploid). Among 107 heterogeneous tumours a majority (79%) contained aneuploid as well as diploid cell clones. Homogeneously diploid tumours had a lower incidence of local tumour spread compared with tumours with aneuploid cell clones (P < or = 0.001), but the frequency of distant metastasis at time of diagnosis was similar. The presence of aneuploidy in at least one sample from a tumour was a significant adverse prognostic factor (P < 0.001), whereas the degree of heterogeneity had no influence on survival. The frequent heterogeneity demonstrated indicates that multiple samples must be investigated to evaluate properly the malignant character of renal cell carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ljungberg, B., Mehle, C., Stenling, R. et al. Heterogeneity in renal cell carcinoma and its impact on prognosis - a flow cytometric study. Br J Cancer 74, 123–127 (1996). https://doi.org/10.1038/bjc.1996.326
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.326
This article is cited by
-
SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth
Cell Death & Disease (2021)
-
A non-diploid DNA status is linked to poor prognosis in renal cell cancer
World Journal of Urology (2021)
-
Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis
Pathology & Oncology Research (2020)
-
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
British Journal of Cancer (2012)
-
Epigenetic regulation in RCC: opportunities for therapeutic intervention?
Nature Reviews Urology (2012)